Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioMatrix AlphaTM (Cobalt Chromium Biolimus A9TM Drug-eluting Stent) - ALPHA LONG Study

NCT05799963 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT05799963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioMatrix AlphaTM (Cobalt Chromium Biolimus A9TM Drug-eluting Stent) - ALPHA LONG Study
Lead sponsor
Biosensors Europe SA
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 9, 2024
Completion date
March 31, 2026
Enrollment
85 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease